Opening Statement – Public Health (Tobacco and Nicotine Inhaling Products) Bill 2019
Tobacco

The Institute of Public Health (IPH) is today appearing before the Oireachtas Joint Committee on Health to give evidence on the Public Health (Tobacco and Nicotine Inhaling Products) Bill 2019. IPH Director of Policy Dr Helen McAvoy joined Professor Des Cox from the Royal College of Physicians Ireland (RCPI) Tobacco Policy Group to give evidence on this proposed legislation. 

IPH and RCPI previously submitted joint written positions on this legislation in January 2020 and in June 2021. Today IPH has welcomed this proposed legislation on tobacco and nicotine inhaling products as ‘proportionate’, based on sound principles and evidence, and complementary to the existing suite of tobacco control legislation and Tobacco Free Ireland policy. 

In an opening statement to the Joint Committee on Health, the Institute said the Public Health (Tobacco and Nicotine Inhaling Products) Bill 2019 will make both tobacco and e-cigarettes less accessible to children and enhance government oversight on the supply of these products.

Latest resources

15 Apr, 2024 - IPH has published a Policy Brief on the UK Tobacco and Vapes Bill and what it will mean for Northern Ireland in the near future. Access the policy brief here. The Bill seeks to reduce…
9 Apr, 2024 - The Institute of Public Health (IPH) has launched a new case study providing practical guidance on how to undertake a Health Impact Assessment (HIA).‘Mellow Village: A Health Impact Assessment Case…
9 Apr, 2024 - New HIA Case Study - practical guidance on how to undertake a Health Impact AssessmentThe Institute of Public Health (IPH) has launched a new hypothetical case study providing practical guidance on…